<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

Milan
Facility

 

Cell Therapy & Viral Vector Manufacturing in Europe

AGC Biologics Milan specializes in cell therapy and viral vector development and manufacturing. The site works with virtually any cell type and lentiviral, retroviral, and adeno‐ associated viral vectors. The facility was the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies. The core scientific team has more than 25 years of expertise in the field and unique knowledge you will not find anywhere else. 

 

Got a project? Let's talk.
Milan-entrance

factsheet thumbnail milan

Get all the details on this site.

Our in-depth fact sheet provides all the details you need on the complete capabilities and services of this campus and its abilities to support your next project. 

DOWNLOAD NOW

Milan Facility Highlights

Hover over each card to learn more

Milan Facility Highlights

Tap on each card to learn more

Cell Therapy Development & Manufacturing

Our cell therapy services can help at any stage, from initial development to full commercial supply. We have GMP manufacturing suites for cell therapy practice in one centralized location where all processes are managed. Using both autologous and allogeneic systems; our team has extensive experience with T cell, HSC / CD34, and NK cell products.  

Cell Therapy Capabilities

_MG_7939

Viral Vector Development & Manufacturing

Our new standardized platforms BravoAAV™ and ProntoLVVoffer an innovative templated approach to AAV and LVV manufacturing. With prequalified scale-down models simplifying and accelerating the path to commercialization, our Milan site can take on any project. We have commercial manufacturing experience with three viral vector products, and 5 PPQ runs completed to support BLA filings.  

Viral Vector Capabilities
_MG_8036

Analytical Development

Our globally aligned quality systems feature a full docket of site-specific processes, specifications, and records, with over 160 analytical tests and 95% of release testing provided in-house including sterility, RCL and adventitious agents.  

Learn more

production_site_019

Fill & Finish

We have the FC-800 O-Rabs filling machine onsite, with capabilities to fill 6R Type I Glass vials and polymeric vials (e.g. COP) with a volume up to 8mL. Max n° of vials filled per batch: 1350 (MF covered). Filling speed: 500 vials/h 100% IPC, 800 vials/h without IPC.  

AGC_Milano_011
 

Watch our Milan Facility Tour

 

Milan

T: +39-02-21277-1
F: +39-02-21277-325
E: contactus@agcbio.com

Openzone
Via Meucci, 3
20091 Bresso (MI), Italy

 

Join our team!

Visit our careers page

 

AGC Biologics S.p.A.,
Registered office: via Meucci 3, 20091 Bresso (MI)
Share capital: € 21.819.020,83 i.v.
REA n.1506630 - Milan Companies' Register/C.F./P.IVA no. 11887610159
Sole shareholder company subject to the management and coordination of AGC Inc.

Looking for more information?

Contact our team

Learn about our other sites:

Seven Sites.

One Quality System.